Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Neutral

Analyst Rating

Strong Buy

Molecular Templates, Inc. (MTEM)

Pharmaceutical Preparations

https://www.mtem.com

Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer.

9301 AMBERGLEN BLVD, SUITE 100
AUSTIN, TX

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/04/2005

Market Cap

9,875,820

Shares Outstanding

5,370,000

Weighted SO

5,374,268

Total Employees

N/A

Upcoming Earnings

08/08/2024

Beta

1.1900

Last Div

0.0000

Range

1.01-9.15

Chg

0.0300

Avg Vol

37016

Mkt Cap

9875820

Exch

NASDAQ

Country

US

Phone

512 869 1555

DCF Diff

0.7257

DCF

1.7557

Div Yield

0.0000

P/S

0.3877

EV Multiple

-2.2177

P/FV

1.3832

Div Yield %

0.0000

P/E

-1.3437

PEG

-0.0410

Payout

0.0000

Current Ratio

1.5646

Quick Ratio

1.5646

Cash Ratio

1.2574

DSO

11.3928

DIO

0.0000

Op Cycle

11.3928

DPO

202.0653

CCC

-190.6725

Gross Margin

0.8033

Op Margin

-0.3369

Pretax Margin

-0.2878

Net Margin

-0.2874

Eff Tax Rate

0.0560

ROA

-0.2742

ROE

-1.2203

ROCE

-0.4512

NI/EBT

0.9985

EBT/EBIT

0.8544

EBIT/Rev

-0.3369

Debt Ratio

0.4130

D/E

1.5507

LT Debt/Cap

0.5413

Total Debt/Cap

0.6080

Int Coverage

-8579.9990

CF/Debt

-2.1696

Equity Multi

3.7543

Rec Turnover

32.0377

Pay Turnover

1.8063

Inv Turnover

0.0000

FA Turnover

1.9062

Asset Turnover

0.9540

OCF/Share

-3.6485

FCF/Share

-3.6485

Cash/Share

1.4727

OCF/Sales

-0.9393

FCF/OCF

1.0000

CF Coverage

-2.1696

ST Coverage

-9.0724

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

1.3832

P/B

1.3832

P/S

0.3877

P/E

-1.3437

P/FCF

-0.4128

P/OCF

-0.4111

P/CF

-0.4111

PEG

-0.0410

P/S

0.3877

EV Multiple

-2.2177

P/FV

1.3832

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation